Corresponding Author: Samyukta Mullangi, MD, MBA, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (smullangi13@gmail.com).
Published Online: January 13, 2021. doi:10.1001/jamainternmed.2020.8710
Conflict of Interest Disclosures: Dr Agrawal reported receiving payment for serving as policy advisor to Governor Ned Lamont of Connecticut. Dr Schulman reported board member and shareholder relationships with Grid Therapeutics, Faculty Connection, LLC, and Reserve Therapeutics. He is also a member of the board of advisors and a shareholder with Prealize. Dr Schulman reported that he is an investor in Altitude Ventures, Inc and Excelerate Health Ventures. He reported receiving consulting fees from Novartis, Inc, Cytokinetics, Inc, Business Roundtable, Motley Rice, LLC, and Frazier Healthcare Partners and speaking fees from Health Quest, LLC and ISMIE, Inc. Dr Schulman also reported nonfinancial relationships with the Business School Alliance for Health Management (president), Civica RX (member of Advisory Board), and Health Services Research (senior associate editor).
2. Medical Board of California Annual Report 2018-2019. Medical Board of California; 2019.
3.Gupta
A , Sao
D. The constitutionality of current legal barriers to telemedicine in the United States: analysis and future directions of its relationship to national and international health care reform.
Health Matrix Clevel. 2011;21(2):385-442.
PubMedGoogle Scholar 4.North Carolina State Board of Dental Examiners v Federal Trade Commission, 574 US 494 (2014).
7. Nurse Licensure Compact: A Biennial Report FY2018-19. Interstate Commission of Nurse Licensure Compact Administrators; 2019.
8. Telemedicine Policies: Board by Board Overview. Federation of State Medical Boards; 2020.
9.Licensing
O . A Framework for Policymakers. White House, Dept of the Treasury Office of Economic Policy, Council of Economic Advisors. Dept of Labor; 2015.